- Phare
- Validé par KD/KO
Anticorps Polyclonal de lapin anti-SETDB1
SETDB1 Polyclonal Antibody for WB, IP, IF, IHC, ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain et plus (1)
Applications
WB, IHC, IF/ICC, IP, CoIP, ChIP, ELISA
Conjugaison
Non conjugué
N° de cat : 11231-1-AP
Synonymes
Galerie de données de validation
Applications testées
Résultats positifs en WB | cellules Jurkat, cellules HEK-293, cellules HeLa, cellules MCF-7, cellules PC-3, tissu testiculaire humain |
Résultats positifs en IP | cellules MCF-7 |
Résultats positifs en IHC | tissu de cancer du poumon humain, tissu testiculaire humain il est suggéré de démasquer l'antigène avec un tampon de TE buffer pH 9.0; (*) À défaut, 'le démasquage de l'antigène peut être 'effectué avec un tampon citrate pH 6,0. |
Résultats positifs en IF/ICC | cellules A431, |
Dilution recommandée
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:500-1:2000 |
Immunoprécipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
Immunohistochimie (IHC) | IHC : 1:50-1:500 |
Immunofluorescence (IF)/ICC | IF/ICC : 1:200-1:800 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Applications publiées
KD/KO | See 21 publications below |
WB | See 58 publications below |
IHC | See 7 publications below |
IF | See 11 publications below |
IP | See 9 publications below |
CoIP | See 3 publications below |
ChIP | See 22 publications below |
Informations sur le produit
11231-1-AP cible SETDB1 dans les applications de WB, IHC, IF/ICC, IP, CoIP, ChIP, ELISA et montre une réactivité avec des échantillons Humain
Réactivité | Humain |
Réactivité citée | Humain, souris |
Hôte / Isotype | Lapin / IgG |
Clonalité | Polyclonal |
Type | Anticorps |
Immunogène | SETDB1 Protéine recombinante Ag1725 |
Nom complet | SET domain, bifurcated 1 |
Masse moléculaire calculée | 143 kDa |
Poids moléculaire observé | 170 kDa |
Numéro d’acquisition GenBank | BC009362 |
Symbole du gène | SETDB1 |
Identification du gène (NCBI) | 9869 |
Conjugaison | Non conjugué |
Forme | Liquide |
Méthode de purification | Purification par affinité contre l'antigène |
Tampon de stockage | PBS avec azoture de sodium à 0,02 % et glycérol à 50 % pH 7,3 |
Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
SETDB1, also named as ESET, KIAA0067 and KMT1E, belongs to the histone-lysine methyltransferase family. It is a SET domain protein with histone H3-K9-specific methyltransferase activity. H3 'Lys-9' trimethylation is coordinated with DNA methylation and represents a specific tag for epigenetic transcriptional repression by recruiting HP1 (CBX1, CBX3 and/or CBX5) proteins to methylated histones. SETDB1 mainly functions in euchromatin regions, thereby playing a central role in the silencing of euchromatic genes. It probably forms a complex with MBD1 and ATF7IP that represses transcription and couples DNA methylation and histone 'Lys-9' trimethylation. Its activity is dependent on MBD1 and is heritably maintained through DNA replication by being recruited by CAF-1. SETDB1 regulates histone methylation, gene silencing, and transcriptional repression. It has been identified as a target for treatment in Huntington Disease, given that gene silencing and transcription dysfunction likely play a role in the disease pathogenesis. This antibody is a rabbit polyclonal antibody raised against residues near the N terminus of human SETDB1.The calculated molecular weight of SETDB1 is 143 kDa, but the modified SETDB1 protein is about 170 kDa (PMID: 11791185).
Protocole
Product Specific Protocols | |
---|---|
WB protocol for SETDB1 antibody 11231-1-AP | Download protocol |
IHC protocol for SETDB1 antibody 11231-1-AP | Download protocol |
IF protocol for SETDB1 antibody 11231-1-AP | Download protocol |
IP protocol for SETDB1 antibody 11231-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
Publications
Species | Application | Title |
---|---|---|
Nature Epigenetic silencing by SETDB1 suppresses tumour intrinsic immunogenicity.
| ||
Nature Genome surveillance by HUSH-mediated silencing of intronless mobile elements.
| ||
Science GENE SILENCING. Epigenetic silencing by the HUSH complex mediates position-effect variegation in human cells.
|
Avis
The reviews below have been submitted by verified Proteintech customers who received an incentive forproviding their feedback.
FH Roy (Verified Customer) (06-28-2024) | Does work well to detect SETDB1 in Jurkat and HeLa cells (Overnight incubation at 4°C, 1/1000 dilution)
|
FH Taku (Verified Customer) (06-15-2022) |
|